Home
About
Overview
Sharing Data
ORCID
Help
History (9)
Investigating Novel Exercise-Induced Molecular Pathways for Cardiometabolic Disease Prevention
Dana K. Andersen, MD: Leader, Visionary, Colleague, and Friend for the Pancreas Community.
Comparison of topical antibiotics for treating Mycobacterium fortuitum keratitis in an animal model.
Comparative efficacy of topical ciprofloxacin for treating Mycobacterium fortuitum and Mycobacterium chelonae keratitis in an animal model.
Mycobacterium fortuitum keratitis. A comparison of topical ciprofloxacin and amikacin in an animal model.
See All 9 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
My Person List (
0
)
Return to Top
Mycobacterium fortuitum keratitis. A comparison of topical ciprofloxacin and amikacin in an animal model.
Mycobacterium fortuitum keratitis. A comparison of topical ciprofloxacin and amikacin in an animal model. Cornea. 1992 Nov; 11(6):500-4.
View in:
PubMed
subject areas
Amikacin
Animals
Ciprofloxacin
Corneal Ulcer
Disease Models, Animal
Eye Infections, Bacterial
Male
Mycobacterium Infections, Nontuberculous
Nontuberculous Mycobacteria
Ophthalmic Solutions
Rabbits
Random Allocation
authors with profiles
Gary N. Holland, MD